Evaluating an HIV Risk Screening Tool for Orphans and Vulnerable Children in Tanzania
NCT ID: NCT04517760
Last Updated: 2020-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21080 participants
OBSERVATIONAL
2018-02-22
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
NCT03343158
Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
NCT01555723
Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland
NCT03397420
Swaziland Safe Generations
NCT01891799
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
NCT00005274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objectives of this study are as follows.
1. To evaluate the performance of a lay cadre-administered four-item subset of the K2 HIV risk screening tool that matches the Zimbabwe evidence-based tool in predicting the HIV status of vulnerable children/adolescents represented by two populations: (a) K2 OVC beneficiaries and (b) children/adolescents attending health facilities.
2. To identify additional items in the K2 HIV risk screening tool that could be added to the four-question subset to improve the tool's performance.
3. To assess fidelity to the administration of the OVC HIV screening tool items through structured observations of community case workers in the K2 program.
4. To assess the acceptability of OVC HIV risk screening and testing implemented in the community among OVC beneficiaries in the K2 program.
5. To assess the acceptability and feasibility of integrating the OVC HIV screening tool with HIV testing among OVC community case workers in the K2 program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attending a study health facility in two regions of Tanzania
* Age 2-19 years
* conducting HIV risk screening in OVC households as part of their role in the Kizazi Kipya project in the subset of study districts where structured observations and focus group discussions were conducted
Exclusion Criteria
* History of antiretroviral treatment (ART)
* Unable or unwilling to be consented
* Age 5-19 years old, tested negative in past 6 months, and having no reported exposure to HIV through sexual contact (consensual, abuse) or through blood transfusion/needle injury.
Community care workers:
* unwilling to consent to the study
2 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanzania Ministry of Health, Community Development, Gender, Elderly and Children
UNKNOWN
PACT International
UNKNOWN
Elizabeth Glaser Pediatric AIDS Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gretchen Antelman, PhD
Role: PRINCIPAL_INVESTIGATOR
E. Glaser Pediatric AIDS Found
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elizabeth Glaser Pediatric AIDS Foundation
Dar es Salaam, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EG0216
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.